At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4 enrolled
Drug / intervention
Amantadine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness
In Brief
A clinical study evaluating rTMS and Amantadine for Traumatic Brain Injury. Completed, enrolled 4 participants across 2 sites.
Detailed Summary
The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTraumatic Brain Injury
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 2014
Enrollment StartFeb 2014
Primary CompletionJul 2016
TodayJul 2026
First PostedJan 1, 2014
Enrollment StartFeb 1, 2014
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 12.5 years ago
Interventions
rTMSdevice
Amantadinedrug